Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • BIOCRYST PHARMACEUTICALS Key Ratios

  • Valuation Ratio: BCRX

    P/E (TTM) -2.11
    Price to CashFlow -32.57
    Price to Sales (TTM) 0.92
    Price to Book 13.56
  • Per Share Ratio: BCRX

    Dividend Per Share (TTM) 0.00
    Book Value Per Share 0.46
    EPS Fully Diluted -0.65
    Revenue Per Share 1.49
  • 5 Year Annual Growth: BCRX

    Net Income
    Revenue 144.00%
    Dividend Per Share (TTM) 0.00%
    EPS
  • Dividends: BCRX

    Dividend Yield 0.00%
    Dividend Yield - 5 Yr. Avg. 0.00%
    Dividend Per Share (TTM) 0.00
    Dividend Payout Ratio 0.00
  • Profit Margins: BCRX

    Operations Margin -48.03%
    Net Profit Margin -43.73%
    Gross Profit Margin 97.13%
  • Financial Strength: BCRX

    Quick Ratio (MRQ) 4.30
    Current Ratio (MRQ) 2.86
    LT Debt to Equity (MRQ) 0.00
    Total Debt to Equity (MRQ) 0.00
    Return on Equity (ROE) Per Share -44.48
    Return on Assets (ROA) -23.18
    Return on Invested Capital (ROIC) -44.43
  • Assets: BCRX

    Asset Turnover 0.67
    Inventory Turnover